Lacosamide Solution
Product Images NDC 72205-034

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 72205-034). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lacosamide-200ml-bottle (Lacosamide 200ml Bottle)

Lacosamide-200ml-bottle (Lacosamide 200ml Bottle)
This is a description for a medication called Lacosamide. It is an oral solution in the form of a 200 mL bottle. Each milliliter of the solution contains 10 mg of lacosamide. The usual dosage information can be found in the package insert. It should be stored at a temperature range of 20°C to 25°C (68°F to 77°F), with excursions between 15°C to 30°C (59°F to 86°F) permitted. The product should not be frozen and any unused product should be discarded after six months of opening the bottle. The medication should be kept out of reach of children and dispensed in the original container or as described in the USP/NF. It is manufactured by MSN Pharmaceuticals Inc. and distributed by Novadoz Pharmaceuticals LLC. The contact number for Novadoz Pharmaceuticals LLC is 855-NOVADOZ (668-2369). The issuing date of the description is 07/2022.*
FDA Label Image

Lacosamide-465ml-bottle (Lacosamide 465ml Bottle)

Lacosamide-465ml-bottle (Lacosamide 465ml Bottle)
This is a description of a medication called Lacosamide. It is an Oral Solution, USP, and each milliliter (mL) of the solution contains 10 mg of lacosamide. The usual dosage information can be found in the package insert. The medication should be stored at a temperature between 20°C to 25°C (68°F to 77°F), with excursions allowed between 15°C to 30°C (59°F to 86°F). It is important to not freeze the medication. Any unused product should be discarded after six months of first opening the bottle. The medication should be kept out of reach of children. It should be dispensed in the original container or as described in USP/NF. The medication is manufactured by MSN Pharmaceuticals Inc. and distributed by Novadoz Pharmaceuticals LLC. For more information, the pharmacist should dispense the accompanying Medication Guide to each patient.*
FDA Label Image

Lacosamide-fig-1 (Lacosamide Fig 1)

FDA Label Image

Lacosamide-fig-2 (Lacosamide Fig 2)

FDA Label Image

Lacosamide-fig-3 (Lacosamide Fig 3)

FDA Label Image

Lacosamide-structure (Lacosamide Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.